Jon Congleton sold $1.9M of MLYS stock

Jon Congleton, Chief Executive Officer of Mineralys Therapeutics, Inc. (MLYS), sold 75,000 shares of MLYS stock worth $1.9M, per an SEC Form 4 filed Oct 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 30, 2026, 2 days before it was made public.

MLYS has moved -38.3% since the trade date, from $25.13 to $15.50 (Nov 12, 2026 close).